Yidu Tech (HKSE:02158) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02158 Yidu Tech Inc HKSE:02158
71 GF Score
Price HK$3.81
GF Value HK$5.93
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Yidu Tech FFO per Share?

FFO per Share only applies to REITs.

HKSE:02158
71GF Score
Yidu Tech Inc HKSE:02158
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Yidu Tech (HKSE:02158) Overvalued in 2026?

Based on GuruFocus' analysis, Yidu Tech stock appears to be undervalued. The current stock price of HK$3.81 is trading 35.8% below its estimated GF Value™ of HK$5.93. GuruFocus considers Yidu Tech to be Possible Value Trap.

Key valuation signals for HKSE:02158:

  • FFO per Share:
  • GF Value™: HK$5.93 vs. price of HK$3.81 (35.8% below fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the HKSE:02158 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Yidu Tech Business Description

Other Exchanges 0EL:Germany
Address Lincui Xili Phase 3, Building 22, Chaoyang District, Beijing, CHN
Yidu Tech Inc offers healthcare solutions built on big data and artificial intelligence (AI) technologies. The company serves various healthcare industry participants, including hospitals, pharmaceutical, biotech, research institutions, insurance companies, etc. Its operating segments are: Big data platform and solutions, Life sciences solutions, and Health management platform and solutions. The majority of the company's revenue is generated from its Big data platform and solutions segment, which provides data intelligence platforms and data analytics-driven solutions (such as Eywa 5.0, Lingxi Intelligent Management, AI Middleware, etc.) for hospitals, healthcare institutions, regulators, and policymakers. Geographically, the company generates maximum revenue from Mainland China.
71GF Score

Get the complete analysis for HKSE:02158

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$3.81
Price
HK$5.93
GF Value